StoneX (SNEX) is rated a Strong Buy with a $144 target, driven by synergies, cross-border payment growth, and durable EPS ...

Roivant Sciences' 44% return highlights potential in its pipeline and partnerships. I maintain a cautious stance on RIOV ...

Invest confidently with Healthpeak (DOC) stock. See here for insights on strong buy potential, stable yield, and portfolio ...

According to a recent report by Mizuho analysts, efficiencies generated by AI could lead to an improvement of up to 7.5% in ...

GitLab (GTLB) outshines Atlassian (TEAM) in KPIs and metrics. Read here for a comparison of Key Performance Indicators for ...

Coherent leverages AI, EV trends, and lasers with a vertical model boosting growth. COHR is prioritizing high-margin segments ...

BOK Financial faces funding cost pressures but shows improving interest margins and strong credit quality. Read more on BOKF ...

Temporary EPS tailwinds to fade, muted volume growth & high leverage weigh on the outlook. See more on CLX stock here.

Markets kicked off the second half of 2025 with a strong finish to Q2, propelled by easing geopolitical fears, falling oil ...

AMC Entertainment settles litigation with creditors, gains $223M cash, reduces net debt by $325M. Share count rises to 600M.

SulNOx's growth relies on equity deals over demand, with high valuation and cash burn. Read here for an in-depth financial ...

See here for an in-depth review of OSCV, a small/mid-cap dividend ETF. Learn about its quality, growth traits, and challenges ...